![](https://www.businessmarketinsights.com/assets/img/reports-icon.png)
亚太代谢组学服务市场预测至 2028 年 - 按服务类型(靶向代谢组学服务和非靶向代谢组学服务)和应用(制药和生物技术行业、农业技术和环境)划分的 COVID-19 影响和区域分析
市场介绍
亚太地区 (APAC) 是代谢组学增长最快的区域市场服务;中国、印度、日本、韩国、澳大利亚和亚太地区其他国家是该地区市场的主要贡献者。由于国际参与者在中国和印度的投资不断增加、各国政府支持的改善、CRO服务基础的扩大以及医疗基础设施的进步,亚太地区可能在2021年占据全球代谢组学服务市场超过25.68%的市场份额。因此,该地区代谢组学服务市场参与者在预测期内具有巨大的增长潜力。日本医疗保健行业正在见证巨大的发展和财政援助,以加速其基于细胞疗法的产品的采用和接受。政府专注于制定法律和政策,以支持再生医学等新型诊断和治疗方法的创新和发现。该国拥有合同研究组织,这反过来又有望支持市场增长。相关市场的参与者正在积极投资日本。多个国家的发展机会是推动亚太地区代谢组学服务市场增长的主要因素。
由于持续的 COVID-19 大流行,医疗保健行业面临着巨大的压力。压力。遏制和社会疏远措施导致供应链中断。此外,对 COVID-19 的有效诊断和治疗的需求在亚太地区变得至关重要。印度、中国、日本和韩国等该地区国家因疫情而遭受各种不利影响,包括社会经济受损、通货膨胀、国内生产总值低迷和失业率激增。中国、日本、新加坡和韩国等国家开展了快速临床试验。西方国家的高运营成本推动医疗事务外包流向亚太地区。为了利用这些机会,该地区的制药公司获得了有关药物、设备和体外诊断的新的和不断变化的监管环境的专业知识。亚洲经常实施新的或改进的法规,包括 GMP 标准、药品价格控制和医疗器械监管体系的变化。任何新标准的获取或改进都需要第三方的指导和建议。第三方外包服务提供商在支持亚太地区相关市场方面发挥着越来越重要的作用。截至 2021 年,由于控制程序、人们的意识、疫苗开发和管理以及促进业务增长的政府支持政策,市场已经稳定。
市场概况和动态
亚太地区代谢组学服务市场预计将从2021年的1.1042亿美元增长到2028年的4.3891亿美元;预计 2021 年至 2028 年复合年增长率为 21.8%。代谢组学是检测组织和生物体液中各种代谢物的不断发展且强大的技术之一。该过程在与癌症疾病相关的分析和研究中具有重要的应用。不同类型癌症患病率的上升预计将在预测期内推动市场发展。癌症诊断在癌症治疗中发挥着重要作用。根据世界卫生组织 (WHO) 2021 年 9 月发布的数据,近 70% 的癌症死亡病例来自该地区的低收入和中等收入国家。因此,癌症发病率的上升预计将激增代谢组学服务的需求,从而推动市场增长。
关键细分市场
亚太地区代谢组学服务市场已根据服务类型、应用和国家/地区进行细分。根据服务类型,亚太地区代谢组学服务市场分为靶向代谢组学服务和非靶向代谢组学服务。目标代谢组学服务领域在 2020 年占据市场主导地位,预计将在预测期内增长最快。根据应用,市场分为制药和生物技术行业、农业技术和环境。制药和生物技术行业在 2020 年占据市场主导地位,预计将在预测期内增长最快。同样,制药和生物技术行业细分为生物标志物发现、药物发现、毒理学测试等。
主要来源和上市公司
u>
准备本亚太地区代谢组学服务市场报告时提到的一些主要一手和二手来源是公司网站、年度报告、财务报告、国家报告、政府文件、统计数据库等。报告中列出的主要公司包括 BASF SE、BGI、biocrates life sciences ag、C-CAMP、Chenomx Inc.、Creative Proteomics、Fred Hutchinson Cancer Research Center 和 RTI International 等。 span>
购买报告的理由
- 了解亚太地区代谢组学服务市场格局,并确定最有可能保证丰厚回报的细分市场
- 保持领先地位了解亚太地区代谢组学服务市场不断变化的竞争格局
- 通过识别最有前景的细分市场,有效规划亚太地区代谢组学服务市场的并购和合作交易销售
- 通过对亚太地区代谢组学服务市场各个细分市场表现的敏锐和全面的分析,帮助做出明智的业务决策
- 获取亚太地区 2021-2028 年各细分市场的市场收入预测。
亚太地区代谢组学服务市场细分
亚太地区代谢组学服务市场 - 按 服务类型
- 靶向代谢组学服务
- 非靶向代谢组学服务
亚太地区代谢组学服务市场 - 按应用
- 制药和生物技术行业
- 生物标志物发现
- 药物发现
- 毒理学测试
- 其他
- 农业科技
- 环境
亚太地区代谢组学服务市场 - 按国家/地区
- 日本
- 中国
- 印度 span>
- 澳大利亚
- 韩国
- 亚太地区其他地区
亚太地区代谢组学服务市场 -公司简介
- 巴斯夫股份公司
- 华大基因
- biocrates生命科学ag
- C-CAMP
- Chenomx Inc.
- 创意蛋白质组学
- 弗雷德·哈钦森癌症研究中心
- RTI国际
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 APAC Metabolomics Services Market – By Service Type
1.3.2 APAC Metabolomics Services Market – By Application
1.3.3 APAC Metabolomics Services Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. APAC Metabolomics Services Market – Market Landscape
4.1 Overview
4.2 APAC PEST Analysis
4.3 Experts Opinion
5. APAC Metabolomics Services Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Soaring Incidences of Cancer
5.1.2 Increasing Adoption of Metabolomics and Investments by Market Players
5.2 Market Restraints
5.2.1 High Cost of Tools, Instruments, and Usage
5.3 Market Opportunities
5.3.1 Development Opportunities in Several Countries
5.4 Future Trends
5.4.1 Usage of Artificial Intelligence (AI) and Biomarkers in Biomarker-Related Analysis and Personalized Therapy
5.5 Impact Analysis
6. Metabolomics Services Market– APAC Analysis
6.1 APAC Metabolomics Services Market Revenue Forecast and Analysis
7. APAC Metabolomics Services Market Revenue and Forecasts to 2028– by Service Type
7.1 Overview
7.2 APAC Metabolomics Services Market, By Service Type 2021 & 2028 (%)
7.3 Targeted Metabolomics Service
7.3.1 Overview
7.3.2 Targeted Metabolomics Service: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
7.4 Untargeted Metabolomics Service
7.4.1 Overview
7.4.2 Untargeted Metabolomics Service: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
8. APAC Metabolomics Services Market Revenue and Forecasts to 2028 – by Application
8.1 Overview
8.2 APAC Metabolomics Services Market Share by Application 2021 & 2028 (%)
8.3 Pharmaceutical and Biotechnology Industry
8.3.1 Overview
8.3.2 Pharmaceutical and Biotechnology Industry: Metabolomics Services Market Revenue and Forecast to 2028 (US$ Mn)
8.3.2.1 Biomarker Discovery
8.3.2.1.1 Overview
8.3.2.1.2 Biomarker Discovery: Metabolomics Services Market Revenue and Forecast to 2028 (US$ Mn)
8.3.2.2 Toxicological Testing
8.3.2.2.1 Overview
8.3.2.2.2 Toxicological Testing: Metabolomics Services Market Revenue and Forecast to 2028 (US$ Mn)
8.3.2.3 Drug Discovery
8.3.2.3.1 Overview
8.3.2.3.2 Drug Discovery: Metabolomics Services Market Revenue and Forecast to 2028 (US$ Mn)
8.3.2.4 Others
8.3.2.4.1 Overview
8.3.2.4.2 Others: Metabolomics Services Market Revenue and Forecast to 2028 (US$ Mn)
8.4 Agritech
8.4.1 Overview
8.4.2 Agritech: Metabolomics Services Market Revenue and Forecast to 2028 (US$ Mn)
8.5 Environment
8.5.1 Overview
8.5.2 Environment: Metabolomics Services Market Revenue and Forecast to 2028 (US$ Mn)
9. APAC Metabolomics Services Market Revenue and Forecasts to 2028 – Country Analysis
9.1.1 Asia Pacific: Metabolomics Services Market Revenue and Forecasts to 2028, By Country (%)
9.1.1.1 Japan: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
9.1.1.1.1 Overview
9.1.1.1.2 Japan: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
9.1.1.1.3 Japan: Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type (US$ Mn)
9.1.1.1.4 Japan: Metabolomics Services Market Revenue and Forecasts to 2028, By Application (US$ Mn)
9.1.1.1.4.1 Japan: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
9.1.1.2 China: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
9.1.1.2.1 Overview
9.1.1.2.2 China: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
9.1.1.2.3 China: Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type (US$ Mn)
9.1.1.2.4 China: Metabolomics Services Market Revenue and Forecasts to 2028, By Application (US$ Mn)
9.1.1.2.4.1 China: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
9.1.1.3 India Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
9.1.1.3.1 Overview
9.1.1.3.2 India: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
9.1.1.3.3 India: Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type (US$ Mn)
9.1.1.3.4 India: Metabolomics Services Market Revenue and Forecasts to 2028, By Application (US$ Mn)
9.1.1.3.4.1 India: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
9.1.1.4 South Korea: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
9.1.1.4.1 Overview
9.1.1.4.2 South Korea: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
9.1.1.4.3 South Korea: Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type (US$ Mn)
9.1.1.4.4 South Korea: Metabolomics Services Market Revenue and Forecasts to 2028, By Application (US$ Mn)
9.1.1.4.4.1 South Korea: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
9.1.1.5 Australia: Metabolomics Services Market Revenue and Forecasts to 2028(US$ Mn)
9.1.1.5.1 Overview
9.1.1.5.2 Australia: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
9.1.1.5.3 Australia: Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type (US$ Mn)
9.1.1.5.4 Australia: Metabolomics Services Market Revenue and Forecasts to 2028, By Application (US$ Mn)
9.1.1.5.4.1 Australia: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
9.1.1.6 Rest of Asia Pacific: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.6.1 Overview
9.1.1.6.2 Rest of Asia Pacific: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.6.3 Rest of Asia Pacific: Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type (US$ Mn)
9.1.1.6.4 Rest of Asia Pacific: Metabolomics Services Market Revenue and Forecasts to 2028, By Application (US$ Mn)
9.1.1.6.4.1 Rest of Asia Pacific: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
10. Impact Of COVID-19 Pandemic on APAC Metabolomics Services Market
10.1 Overview
11. APAC Metabolomics Services Market–Industry Landscape
11.1 Overview
11.2 Organic Developments
11.2.1 Overview
11.3 Inorganic Developments
11.3.1 Overview
12. Company Profiles
12.1 BASF SE
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Creative Proteomics
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 BGI
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 RTI International
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Fred Hutchinson Cancer Research Center
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 biocrates life sciences ag
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Chenomx Inc.
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 C-CAMP
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. APAC Metabolomics Services Market Revenue and Forecast to 2028 (US$ Million)
Table 2. Japan: Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type (US$ Mn)
Table 3. Japan: Metabolomics Services Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 4. Japan: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
Table 5. China: Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type (US$ Mn)
Table 6. China: Metabolomics Services Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 7. China: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
Table 8. India: Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type (US$ Mn)
Table 9. India: Metabolomics Services Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 10. India: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
Table 11. South Korea: Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type (US$ Mn)
Table 12. South Korea: Metabolomics Services Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 13. South Korea: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
Table 14. Australia: Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type (US$ Mn)
Table 15. Australia: Metabolomics Services Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 16. Australia: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
Table 17. Rest of Asia Pacific: Metabolomics Services Market Revenue and Forecasts to 2028, By Service Type (US$ Mn)
Table 18. Rest of Asia Pacific: Metabolomics Services Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 19. Rest of Asia Pacific: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
Table 20. Organic Developments Done By Companies
Table 21. Inorganic Developments Done By Companies
Table 22. Glossary of Terms, APAC Metabolomics Services Market
LIST OF FIGURES
Figure 1. APAC Metabolomics Services Market Segmentation
Figure 2. APAC Metabolomics Services Market, By Country
Figure 3. APAC Metabolomics Services Market Overview
Figure 4. Targeted Metabolomics Service Segment Held Largest Share of Type Segment in APAC Metabolomics Services Market
Figure 5. India is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. APAC PEST Analysis
Figure 7. Experts Opinion
Figure 8. Impact Analysis of Drivers and Restraints Pertaining to APAC Metabolomics Services Market
Figure 9. APAC Metabolomics Services Market– By Revenue Forecast and Analysis – 2019- 2028
Figure 10. APAC Metabolomics Services Market, by Service Type 2021 & 2028 (%)
Figure 11. APAC Targeted Metabolomics Service: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 12. APAC Untargeted Metabolomics Service: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 13. APAC Metabolomics Services Market Share by Application 2021 & 2028 (%)
Figure 14. APAC Pharmaceutical and Biotechnology Industry: Metabolomics Services Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 15. APAC Biomarker Discovery: Metabolomics Services Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 16. APAC Toxicological Testing: Metabolomics Services Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 17. APAC Drug Discovery: Metabolomics Services Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 18. APAC Others : Metabolomics Services Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 19. APAC Agritech: Metabolomics Services Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 20. APAC Environment: Metabolomics Services Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 21. Asia Pacific Metabolomics Services Market Overview, by Country (2021)
Figure 22. Asia Pacific: Metabolomics Services Market Revenue and Forecasts to 2028, By Country (%)
Figure 23. Japan: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 24. China: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 25. India: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 26. South Korea: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 27. Australia: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 28. Rest of Asia Pacific: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
Figure 29. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
- BASF SE
- BGI
- biocrates life sciences ag
- C-CAMP
- Chenomx Inc.
- Creative Proteomics
- Fred Hutchinson Cancer Research Center
- RTI International
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the APAC Metabolomics Services market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the APAC Metabolomics Services market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth APAC market trends and outlook coupled with the factors driving the Metabolomics Services market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution